Acta Pharmaceutica Sinica B (May 2024)

Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics

  • Rabea Voget,
  • Julian Breidenbach,
  • Tobias Claff,
  • Alexandra Hingst,
  • Katharina Sylvester,
  • Christian Steinebach,
  • Lan Phuong Vu,
  • Renato H. Weiße,
  • Ulrike Bartz,
  • Norbert Sträter,
  • Christa E. Müller,
  • Michael Gütschow

Journal volume & issue
Vol. 14, no. 5
pp. 2349 – 2357

Abstract

Read online

A titrant for the SARS-CoV-2 main protease (Mpro) was developed that enables, for the first time, the exact determination of the concentration of the enzymatically active Mpro by active-site titration. The covalent binding mode of the tetrapeptidic titrant was elucidated by the determination of the crystal structure of the enzyme–titrant complex. Four fluorogenic substrates of Mpro, including a prototypical, internally quenched Dabcyl-EDANS peptide, were compared in terms of solubility under typical assay conditions. By exploiting the new titrant, key kinetic parameters for the Mpro-catalyzed cleavage of these substrates were determined.

Keywords